OVARIAN CARCINOMA: IMPROVEMENT IN SURVIVAL TIME AFTER CHEMOTHERAPY

Nye, E. B.

Oxford, UK : Blackwell Publishing Ltd
Published 1972
ISSN:
1471-0528
Source:
Blackwell Publishing Journal Backfiles 1879-2005
Topics:
Medicine
Notes:
A series of 667 cases of ovarian cancer have been studied; 176 patients had triethylene thiophosphoramide chemotherapy and were matched with controls which had not received chemotherapy.In the group with widespread cancer a significantly greater number of treated patients than controls were alive at all times of analysis up to three years after operation. Possible sources of bias have been critically analyzed. Despite close matching, and the apparently favourable result, it was not possible to prove that chemotherapy prolongs survival and a large-scale prospective controlled trail of chemotherapy in ovarian cancer is still necessary and would be justifiable.
Type of Medium:
Electronic Resource
URL:
_version_ 1798289968133570561
autor Nye, E. B.
book_url http://dx.doi.org/10.1111/j.1471-0528.1972.tb14199.x
datenlieferant nat_lic_papers
hauptsatz hsatz_simple
identnr NLZ23879279X
insertion_date 2012-04-17
issn 1471-0528
journal_name BJOG
materialart 1
notes A series of 667 cases of ovarian cancer have been studied; 176 patients had triethylene thiophosphoramide chemotherapy and were matched with controls which had not received chemotherapy.In the group with widespread cancer a significantly greater number of treated patients than controls were alive at all times of analysis up to three years after operation. Possible sources of bias have been critically analyzed. Despite close matching, and the apparently favourable result, it was not possible to prove that chemotherapy prolongs survival and a large-scale prospective controlled trail of chemotherapy in ovarian cancer is still necessary and would be justifiable.
package_name Blackwell Publishing
publikationsjahr_anzeige 1972
publikationsjahr_facette 1972
publikationsjahr_intervall 8029:1970-1974
publikationsjahr_sort 1972
publikationsort Oxford, UK
publisher Blackwell Publishing Ltd
reference 79 (1972), S. 0
search_space articles
shingle_author_1 Nye, E. B.
shingle_author_2 Nye, E. B.
shingle_author_3 Nye, E. B.
shingle_author_4 Nye, E. B.
shingle_catch_all_1 Nye, E. B.
OVARIAN CARCINOMA: IMPROVEMENT IN SURVIVAL TIME AFTER CHEMOTHERAPY
Blackwell Publishing Ltd
A series of 667 cases of ovarian cancer have been studied; 176 patients had triethylene thiophosphoramide chemotherapy and were matched with controls which had not received chemotherapy.In the group with widespread cancer a significantly greater number of treated patients than controls were alive at all times of analysis up to three years after operation. Possible sources of bias have been critically analyzed. Despite close matching, and the apparently favourable result, it was not possible to prove that chemotherapy prolongs survival and a large-scale prospective controlled trail of chemotherapy in ovarian cancer is still necessary and would be justifiable.
1471-0528
14710528
shingle_catch_all_2 Nye, E. B.
OVARIAN CARCINOMA: IMPROVEMENT IN SURVIVAL TIME AFTER CHEMOTHERAPY
Blackwell Publishing Ltd
A series of 667 cases of ovarian cancer have been studied; 176 patients had triethylene thiophosphoramide chemotherapy and were matched with controls which had not received chemotherapy.In the group with widespread cancer a significantly greater number of treated patients than controls were alive at all times of analysis up to three years after operation. Possible sources of bias have been critically analyzed. Despite close matching, and the apparently favourable result, it was not possible to prove that chemotherapy prolongs survival and a large-scale prospective controlled trail of chemotherapy in ovarian cancer is still necessary and would be justifiable.
1471-0528
14710528
shingle_catch_all_3 Nye, E. B.
OVARIAN CARCINOMA: IMPROVEMENT IN SURVIVAL TIME AFTER CHEMOTHERAPY
Blackwell Publishing Ltd
A series of 667 cases of ovarian cancer have been studied; 176 patients had triethylene thiophosphoramide chemotherapy and were matched with controls which had not received chemotherapy.In the group with widespread cancer a significantly greater number of treated patients than controls were alive at all times of analysis up to three years after operation. Possible sources of bias have been critically analyzed. Despite close matching, and the apparently favourable result, it was not possible to prove that chemotherapy prolongs survival and a large-scale prospective controlled trail of chemotherapy in ovarian cancer is still necessary and would be justifiable.
1471-0528
14710528
shingle_catch_all_4 Nye, E. B.
OVARIAN CARCINOMA: IMPROVEMENT IN SURVIVAL TIME AFTER CHEMOTHERAPY
Blackwell Publishing Ltd
A series of 667 cases of ovarian cancer have been studied; 176 patients had triethylene thiophosphoramide chemotherapy and were matched with controls which had not received chemotherapy.In the group with widespread cancer a significantly greater number of treated patients than controls were alive at all times of analysis up to three years after operation. Possible sources of bias have been critically analyzed. Despite close matching, and the apparently favourable result, it was not possible to prove that chemotherapy prolongs survival and a large-scale prospective controlled trail of chemotherapy in ovarian cancer is still necessary and would be justifiable.
1471-0528
14710528
shingle_title_1 OVARIAN CARCINOMA: IMPROVEMENT IN SURVIVAL TIME AFTER CHEMOTHERAPY
shingle_title_2 OVARIAN CARCINOMA: IMPROVEMENT IN SURVIVAL TIME AFTER CHEMOTHERAPY
shingle_title_3 OVARIAN CARCINOMA: IMPROVEMENT IN SURVIVAL TIME AFTER CHEMOTHERAPY
shingle_title_4 OVARIAN CARCINOMA: IMPROVEMENT IN SURVIVAL TIME AFTER CHEMOTHERAPY
sigel_instance_filter dkfz
geomar
wilbert
ipn
albert
source_archive Blackwell Publishing Journal Backfiles 1879-2005
timestamp 2024-05-06T08:09:16.054Z
titel OVARIAN CARCINOMA: IMPROVEMENT IN SURVIVAL TIME AFTER CHEMOTHERAPY
titel_suche OVARIAN CARCINOMA: IMPROVEMENT IN SURVIVAL TIME AFTER CHEMOTHERAPY
topic WW-YZ
uid nat_lic_papers_NLZ23879279X